1,721,166 research outputs found

    GREMO: a GT4 based Resource Monitor

    No full text
    The past few years have seen the Grid rapidly evolving towards a service-oriented computing infrastructure.With the OGSA facilitating this revolution, it is expected that WSRF will be acting as the main an enabling technology to drive the Grid further. Resource monitoring plays a critical role in managing a large-scale Grid system. This paper presents GREMO, a lightweight resource monitor developed with Globus Toolkit 4 (GT4) for monitoring CPU and memory of computing nodes in a Windows and Linux environments

    Análisis del fallo “Gremo”

    No full text
    En la nota a fallo "Gremo, María Teresa y otros c/ Corp. Intercomunal para la gestión sustentable de los residuos del área METROP CBA. S.A. (CORMECOR S.A.) – Amparo (Ley 4915) – Cuerpo de Copias -Recurso de Apelación” se analiza porque adquiere importancia jurídica al resolver un conflicto muy frecuente en materia ambiental referido a la articulación del amparo como medida de cese de actividades que provocan daños ambientales

    Muscarinic receptor subclasses in retinal cultures: effect of corticosterone.

    No full text
    We have previously shown that exogenously administered corticosterone affects muscarinic receptor binding in the chick embryo retina. Analysis with the selective antagonist pirenzepine has shown that both muscarinic receptor subclasses M1 and M2 are present in treated retinas. On the contrary, only M2 is detectable in controls. Moreover, receptor affinity for agonists is modified by hormone treatment. Since these studies did not show whether or not the hormone directly influences retinal cells, a similar study was performed on retinal tissue cultures. Cells were treated at day 5 in vitro for 24 hr with 1.10(-8) M corticosterone. Scatchard analysis of results obtained with 3H-quinuclidinyl benzilate (3H-QNB) binding showed no difference between treated and control cultures. However, displacement experiments demonstrated that both M1 and M2 were present in treated cultures, whereas controls had only M2. Also, receptor affinity for the agonist carbachol was modified, as already observed with in vivo studies. In addition, a new phenomenon was observed: treated cultures had a significantly higher number of cells. The possibility that the hormone can prevent cell death or stimulate cell mitosis is considered
    corecore